Document is current
Any future updates will be listed below
-
Authors
Kościńska-Shukla, Iga https://orcid.org/0000-0001-7821-0671
Jaskólska, Marta https://orcid.org/0000-0002-1408-4490
Grochowalska, Kinga https://orcid.org/0000-0002-6704-1873
Okrój, Marcin https://orcid.org/0000-0003-2935-2301
Chmielewski, Michał https://orcid.org/0000-0001-8126-8786
- License Information
-
More Information
Article History
Received: 30 March 2025
Accepted: 13 May 2025
First Online: 26 May 2025
Declarations
:
: Presented clinical data constituted a part of conference presentation during 25th Congress of the Polish Society for Rheumatology (Potential vitamin B6 toxicity from a rheumatologist’s perspective; Kinga Grochowalska, Marta Magdalena Jaskólska, Iga Kościńska-Shukla, Michał Chmielewski; Reumatologia 2024;62 (Suppl 1)(XXV KONGRES POLSKIEGO TOWARZYSTWA REUMATOLOGICZNEGO):80–81; DOI: ). The review has not been previously published neither in part nor as a full text. The article meets the criteria for publication under the Springer Open Choice Programme.
: Iga Kościńska-Shukla gave two lectures sponsored by Woerwag Pharma on the safety of treatment with group B vitamins formulations. This cooperation did not influence the results published in this article.
